Stabilized oxymetazoline formulations and their uses
US12350255B2 · kind B2 · utility
0Cited by
12References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 1, 2022 |
| Grant date | Jul 8, 2025 |
| Priority date | — |
| Expiry date | Feb 6, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P17/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides stabilized cream formulations of oxymetazoline and uses thereof. The present invention also provides a method of treating facial erythema associated with rosacea in a patient in need of such treatment, comprising topically administering once or twice daily to the site of erythema on the face of the patient a pharmaceutical composition comprising 0.5%, 1.0% or 1.5% oxymetazoline or a pharmaceutically acceptable salt thereof as the sole active ingredient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.